Similarly, in HCC samples, immunohistochemical staining demonstrated lower levels of SOCS2 protein expression in patients with HCC [31], whilst Liu et al. suggested SOCS2 is a protective factor, because its high expression improves the prognosis of HCC patients [32]. The gene discussed is SOCS2; the disease is hepatocellular carcinoma.